Atossa Therapeutics
ATOS
#9496
Rank
โ‚น7.13 B
Marketcap
โ‚น55.27
Share price
0.05%
Change (1 day)
-26.51%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: โ‚น7.13 Billion

As of January 2026 Atossa Therapeutics has a market cap of โ‚น7.13 Billion. This makes Atossa Therapeutics the world's 9496th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น7.13 B-6.55%
2025โ‚น7.64 B-27.84%
2024โ‚น10.58 B15.34%
2023โ‚น9.17 B65.77%
2022โ‚น5.53 B-63.28%
2021โ‚น15.07 B356.47%
2020โ‚น3.30 B223.15%
2019โ‚น1.02 B145.16%
2018โ‚น0.41 B-21.97%
2017โ‚น0.53 B47.24%
2016โ‚น0.36 B-47.74%
2015โ‚น0.69 B-68.81%
2014โ‚น2.22 B-16.38%
2013โ‚น2.66 B-3.5%
2012โ‚น2.75 B

End of Day market cap according to different sources

On Jan 21st, 2026 the market cap of Atossa Therapeutics was reported to be:

โ‚น7.13 Billion
by Nasdaq info icon info icon
โ‚น7.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น48.121 T 673,910.43%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น2.049 T 28,599.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น1.891 T 26,396.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น3.35 B-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น258.71 B 3,523.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น150.42 B 2,006.95%๐Ÿ‡บ๐Ÿ‡ธ USA